AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 34 min read$ADUS

Addus HomeCare Corp (ADUS): Results of Operations and Financial Condition

Addus HomeCare Corp (ADUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contacts: Brian W. Poff Dru Anderson Executive Vice President, Chief Financial Officer FINN Partners Addus HomeCare Corporation (615) 324-7346 (469) 535-8200 dru.anderson@finnpartners.com investorrelations@addus.com ADDUS HOMECARE ANNOUNCES SECOND QUARTER 2026 FINANC

Original reporting
SEC EDGAR 8-K
Published Aug 3, 2026, 8:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$ADUS
Bullish
medium confidence
Mentioned
$ADUS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ADUSBullishMed
01

Why it matters

The filing updates the market with concrete operating and profitability figures, plus liquidity and leverage context, which can shift expectations for near-term earnings power and acquisition capacity.

02

Market read

Investors get fresh quarter datapoints: revenue growth, adjusted EBITDA growth, higher adjusted EPS, and operating cash flow, alongside commentary on organic momentum and state rate tailwinds.

03

What to watch

The excerpt does not include full guidance or detailed segment margins; traders may need to verify whether home health admission trends translate into sustained profitability beyond the quarter.

Relevance 7/10Novelty 8/10Timing: after-hours filing on Aug 3, 2026 (Q2 and six-month results)

Background

This is an SEC 8-K with Exhibit 99.1 announcing Addus HomeCare’s Q2 2026 financial results and six-month totals ended June 30, 2026.

Company-level read

Ticker impact

$ADUSBullishMedium confidence
Context

Addus HomeCare reported Q2 2026 results with net service revenues up 8.0% to $377.4M and adjusted EBITDA up 11.9% to $49.2M.

Expected impact

Likely positive bias for ADUS shares on earnings-day positioning, with follow-through dependent on whether investors focus on organic growth, rate tailwinds, and acquisition contribution.

Evidence & confidence

The filing provides multiple hard datapoints (revenue, net income, adjusted EBITDA, cash flow, liquidity) and management commentary on organic growth, state rate increases, and HomeCourt acquisition contribution, which are typical drivers of post-earnings repricing.

Market effects

Sector

Reinforces demand and pricing power in home care and hospice services, potentially supporting sentiment for other operators with similar payer-rate exposure.

Regional

Highlights Texas and Illinois rate increases as a driver, which may matter for regional peers with similar state footprints.

Global

Limited direct global impact; primarily a US healthcare services read-through.

Counterpoint

What could challenge this read

Adjusted metrics and acquisition contribution may mask underlying margin pressure or normalization risk if rate tailwinds fade.

Key entities

  • public_company
    Addus HomeCare Corporation

    NASDAQ-listed home care services provider reporting Q2 2026 results in an SEC 8-K.

  • executive
    Dirk Allison

    Chairman and CEO quoted on revenue growth drivers, rate increases, and acquisition contribution.

Read at source← All news

Related articles

SEP 14
$ADUSHighAI 9/10

Addus Dips on Buying AccentCare

Addus HomeCare (ADUS) agreed to buy AccentCare's personal care division for $275M, excluding NY operations. The deal adds 13,700 customers in 10 states, boosting revenue by $280M (19%) and is expected to be accretive. Addus will fund the acquisition with revolver and cash. CEO Dirk Allison called it aligned with growth plans.

baystreet.ca2 min
AUG 22
$ADUSMed

The Bull Case For Addus HomeCare (ADUS) Could Change Following COO Leadership Shift - Learn Why

Addus HomeCare (ADUS) announced COO Heather Dixon's departure and Brad Bickham's return as interim COO. Bickham's past experience in acquisitions and platform building may influence the company's growth strategy. Key risks include reimbursement exposure to Medicare and Medicaid, while Q2 2026 debt reduction to $64.3M suggests potential for larger acquisitions. Analysts project $1.7B revenue and $142.2M earnings by 2029, with varying views on policy and labor risks.

simplywall.st2 min
SEP 15
$HAINHighAI 8/10

Hain Celestial (HAIN) Q1 2027 Earnings Call Transcript

Hain Celestial (HAIN) reported Q1 2027 net sales of $263M, down 28% YoY due to divestitures. Organic sales fell 2%, while adjusted gross margin rose to 22.7%. Adjusted EBITDA declined to $19M, and net loss widened to $0.05 per share. The company plans to sell its International business for $323M, focusing on North American operations. Full-year free cash flow improved to $58M, and net debt reduced by $151M. Management expects $16M in annual cost savings and plans to increase marketing investment

fool.com3 min
SEP 15
$AVOMedAI 8/10

Acquisition Momentum Offset by Profitability Headwinds for Mission Produce (AVO)

Mission Produce (AVO) reported Q3 FY26 adjusted EBITDA of $32.4M, beating expectations. Revenue rose 26% YoY to $450M, driven by avocado supply growth and the Calavo acquisition. However, profitability declined, with adjusted net income down YoY. Q4 adjusted EBITDA is projected at $52M-$55M, incorporating Calavo benefits. Institutional investment remained steady, with 20 hedge funds holding shares.

insidermonkey.com2 min